Trust Company of Oklahoma’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Sell
7,066
-83
-1% -$39.8K 0.91% 25
2026
Q1
$3.51M Buy
7,149
+50
+0.7% +$27.1K 1.02% 27
2025
Q4
$4.11M Sell
7,099
-332
-4% -$188K 1.2% 18
2025
Q3
$3.6M Sell
7,431
-157
-2% -$73.1K 1.07% 22
2025
Q2
$3.08M Sell
7,588
-1,203
-14% -$503K 0.98% 25
2025
Q1
$4.37M Sell
8,791
-197
-2% -$107K 1.51% 18
2024
Q4
$4.68M Sell
8,988
-184
-2% -$101K 1.49% 16
2024
Q3
$5.67M Buy
9,172
+592
+7% +$350K 1.84% 13
2024
Q2
$4.74M Sell
8,580
-122
-1% -$69.9K 1.67% 14
2024
Q1
$5.06M Sell
8,702
-70
-0.8% -$39.3K 1.8% 13
2023
Q4
$4.66M Buy
8,772
+26
+0.3% +$12.6K 1.74% 14
2023
Q3
$4.43M Sell
8,746
-132
-1% -$70.3K 1.77% 14
2023
Q2
$4.63M Sell
8,878
-118
-1% -$63.7K 1.71% 14
2023
Q1
$5.19M Sell
8,996
-684
-7% -$386K 2.03% 11
2022
Q4
$5.33M Buy
9,680
+1,452
+18% +$769K 2.15% 11
2022
Q3
$4.17M Sell
8,228
-87
-1% -$48.7K 2.1% 10
2022
Q2
$4.52M Sell
8,315
-4
-0% -$2.2K 2.13% 10
2022
Q1
$4.91M Sell
8,319
-1,308
-14% -$751K 1.88% 13
2021
Q4
$6.42M Sell
9,627
-340
-3% -$212K 2.17% 13
2021
Q3
$5.69M Sell
9,967
-201
-2% -$110K 2.04% 13
2021
Q2
$5.13M Sell
10,168
-278
-3% -$131K 1.74% 15
2021
Q1
$4.77M Sell
10,446
-295
-3% -$141K 1.71% 16
2020
Q4
$5M Sell
10,741
-342
-3% -$160K 1.82% 14
2020
Q3
$4.89M Buy
+11,083
New +$4.58M 2.01% 13
2020
Q1
$3M Buy
10,586
+247
+2% +$77.9K 1.56% 19
2019
Q4
$3.36M Buy
10,339
+12
+0.1% +$3.64K 1.33% 22
2019
Q3
$3.01M Buy
10,327
+286
+3% +$81.9K 1.32% 22
2019
Q2
$2.95M Sell
10,041
-8
-0.1% -$2.2K 1.32% 19
2019
Q1
$2.75M Sell
10,049
-296
-3% -$73.7K 1.25% 22
2018
Q4
$2.32M Sell
10,345
-116
-1% -$27.2K 1.23% 24
2018
Q3
$2.55M Sell
10,461
-47
-0.4% -$10.8K 1.17% 21
2018
Q2
$2.18M Sell
10,508
-976
-8% -$207K 1.08% 23
2018
Q1
$2.37M Sell
11,484
-218
-2% -$45.8K 1.14% 23
2017
Q4
$2.22M Sell
11,702
-1,378
-11% -$264K 1.06% 26
2017
Q3
$2.47M Sell
13,080
-223
-2% -$40.4K 1.24% 23
2017
Q2
$2.32M Buy
13,303
+230
+2% +$38.6K 1.19% 26
2017
Q1
$2.01M Sell
13,073
-6
-0% -$917 1.04% 31
2016
Q4
$1.85M Sell
13,079
-1,948
-13% -$287K 0.99% 32
2016
Q3
$2.39M Sell
15,027
-76
-0.5% -$11.7K 1.31% 21
2016
Q2
$2.23M Sell
15,103
-176
-1% -$26K 1.24% 22
2016
Q1
$2.16M Buy
15,279
+340
+2% +$45.6K 1.2% 23
2015
Q4
$2.12M Buy
14,939
+273
+2% +$36.4K 1.18% 24
2015
Q3
$1.79M Buy
14,666
+826
+6% +$108K 1.04% 27
2015
Q2
$1.8M Sell
13,840
-480
-3% -$62.6K 0.95% 30
2015
Q1
$1.92M Sell
14,320
-2,147
-13% -$277K 0.95% 32
2014
Q4
$2.06M Buy
16,467
+115
+0.7% +$14K 1.02% 29
2014
Q3
$1.99M Buy
16,352
+3,712
+29% +$451K 1% 33
2014
Q2
$1.49M Buy
12,640
+7,813
+162% +$920K 0.72% 45
2014
Q1
$580K Buy
4,827
+115
+2% +$13.7K 0.38% 60
2013
Q4
$525K Sell
4,712
-96
-2% -$9.55K 0.35% 61
2013
Q3
$443K Sell
4,808
-548
-10% -$49.6K 0.33% 63
2013
Q2
$453K Buy
+5,356
New +$446K 0.35% 62

Other funds holding TMO

Trust Company of Oklahoma's TMO Position: Q2 2026 in Review

Trust Company of Oklahoma reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $39.8K and leaving 7,066 shares worth $3.54M. The position accounts for 0.91% of the portfolio, ranked #25.

Trust Company of Oklahoma first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.42M in Q4 2021. 1,156 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Trust Company of Oklahoma held 7,066 shares of Thermo Fisher Scientific worth $3.54M as of Q2 2026.
  • Trust Company of Oklahoma sold 83 Thermo Fisher Scientific shares in Q2 2026, an estimated $39.8K.
  • Thermo Fisher Scientific made up 0.91% of Trust Company of Oklahoma's portfolio in Q2 2026, its #25 holding.
  • Trust Company of Oklahoma first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Trust Company of Oklahoma's Thermo Fisher Scientific position peaked at $6.42M in Q4 2021.
  • 1,156 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Trust Company of Oklahoma's 13F filing for Q2 2026, filed 14 Jul 2026.